Skip to main content
Top
Published in: Alzheimer's Research & Therapy 1/2015

Open Access 01-12-2015 | Commentary

The cost-effectiveness challenge: is it worth it?

Author: Martin Knapp

Published in: Alzheimer's Research & Therapy | Issue 1/2015

Login to get access

Abstract

Scarcity of resources means that difficult choices have to be made about how to use them. Cost-effectiveness evidence provides a way to help decision-makers get ‘best value’ from their resources when choosing between two or more clinical or other interventions. Often it is found that one intervention has better outcomes than another, but also costs more. In these circumstances there is a need for the decision-maker to reach a view as to whether those better outcomes are ‘worth’ the higher costs, necessitating difficult trade-offs. Illustrations from the dementia field are given to illustrate how these trade-offs might be made. For strategic decisions it has often proved helpful to use a generic outcome measure such as the quality-adjusted life year. The fundamental aim of a healthcare system is not to save money, but to save and improve lives. Cost-effectiveness and similar analyses can help by showing how to get the most out of available resources.
Literature
1.
go back to reference Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry. 2003;183:248–54.PubMedCrossRef Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial. Br J Psychiatry. 2003;183:248–54.PubMedCrossRef
2.
go back to reference Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, et al. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry. 2006;188:574–80.PubMedCrossRef Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, et al. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry. 2006;188:574–80.PubMedCrossRef
3.
go back to reference Group EQL. EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef Group EQL. EuroQoL: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef
4.
go back to reference Smith S, Lamping D, Banerjee S, Harwood R, Foley B, Smith P, et al. Development of a new measure of health-related quality of life for people with dementia: DEMQOL. Psychol Med. 2007;37:737–46.PubMedCrossRef Smith S, Lamping D, Banerjee S, Harwood R, Foley B, Smith P, et al. Development of a new measure of health-related quality of life for people with dementia: DEMQOL. Psychol Med. 2007;37:737–46.PubMedCrossRef
5.
go back to reference Mulhern B, Rowen D, Brazier J, Smith SC, Romeo R, Tait R, et al. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation. Health Technol Assess. 2013;17:1–160.CrossRef Mulhern B, Rowen D, Brazier J, Smith SC, Romeo R, Tait R, et al. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation. Health Technol Assess. 2013;17:1–160.CrossRef
6.
go back to reference Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D, et al. The START study (STrAtegies for RelaTives): clinical effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia: a pragmatic randomised controlled trial. Br Med J. 2013;347:f6276.CrossRef Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D, et al. The START study (STrAtegies for RelaTives): clinical effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia: a pragmatic randomised controlled trial. Br Med J. 2013;347:f6276.CrossRef
7.
go back to reference Knapp M, King D, Romeo R, Schehl B, Barber J, Griffin M, et al. The START study (STrAtegies for RelaTives): cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of family carers of people with dementia: a pragmatic randomised controlled trial. Br Med J. 2013;347:f6342.CrossRef Knapp M, King D, Romeo R, Schehl B, Barber J, Griffin M, et al. The START study (STrAtegies for RelaTives): cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of family carers of people with dementia: a pragmatic randomised controlled trial. Br Med J. 2013;347:f6342.CrossRef
8.
go back to reference National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2008. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2008.
9.
go back to reference Cerri K, Knapp M, Fernandez J-L. Taking evidence, process and context into account - a multivariate analysis of NICE decision-making. Health Econ Policy Law. 2014;9:119–42.PubMedCrossRef Cerri K, Knapp M, Fernandez J-L. Taking evidence, process and context into account - a multivariate analysis of NICE decision-making. Health Econ Policy Law. 2014;9:119–42.PubMedCrossRef
10.
go back to reference Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D, et al. Long-term clinical and cost-effectiveness of START (STrAtegies for RelaTives) psychological intervention for family carers and the effects on cost of care for people with dementia: a randomised controlled trial. Lancet Psychiatry. doi:10.1016/S2215-0366(14)00073-X. Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D, et al. Long-term clinical and cost-effectiveness of START (STrAtegies for RelaTives) psychological intervention for family carers and the effects on cost of care for people with dementia: a randomised controlled trial. Lancet Psychiatry. doi:10.1016/S2215-0366(14)00073-X.
11.
go back to reference Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. Br Med J. 2011;342:d1766.CrossRef Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. Br Med J. 2011;342:d1766.CrossRef
12.
go back to reference Knapp M, Iemmi V, Romeo R. Dementia care costs and outcomes: a systematic review. Int J Geriatr Psychiatry. 2012;28:555–61. Knapp M, Iemmi V, Romeo R. Dementia care costs and outcomes: a systematic review. Int J Geriatr Psychiatry. 2012;28:555–61.
Metadata
Title
The cost-effectiveness challenge: is it worth it?
Author
Martin Knapp
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Alzheimer's Research & Therapy / Issue 1/2015
Electronic ISSN: 1758-9193
DOI
https://doi.org/10.1186/s13195-015-0095-4

Other articles of this Issue 1/2015

Alzheimer's Research & Therapy 1/2015 Go to the issue